To study the effect of intranasal Insulin with oral Semaglutide to improve glucose uptake, cognition, cerebral blood flow and related blood biomarkers in older adults with metabolic syndrome and MCI. (COMMETS‐Combination MCI Metabolic Syndrome). The gene discussed is INS; the disease is metabolic syndrome.